Episode 850
TWiV 850: COVID-19 clinical update #96 with Dr. Daniel Griffin
January 8, 202255m 56s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #96, Daniel Griffin reviews Omicron in South Africa, rapid antigen tests, viral coinfections, isolation and quarantine, saliva preferred for Omicron, risk factors for severe disease in vaccinated, Paxlovid dosing, and long COVID.
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Variant proportions (CDC)
- Omicron in South Africa (JAMA)
- Transmission of SARS-CoV-2 (Ann Int Med)
- Diagnostics for COVID-19 (Lancet)
- Comparison of rapid antigen tests (J Clin Med)
- Rapid antigen tests to reduce isolation (medRxiv)
- Frequency of viral confections (MMWR)
- Isolation and quarantine (CDC)
- Saliva preferred for Omicron (medRxiv)
- Risk factors for severe COVID in vaccinated (MMWR)
- Paxlovid dosing (Pfizer)
- Fatigue and cognitive impairment (Brain, Behavior, Immune)
- Letters read on TWiV 850
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]